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Whole-Blood Taurine Concentrations in Cats With Intestinal Disease
A. Kathrani , A.J. Fascetti, J.A. Larsen, C. Maunder, and E.J. Hall
Background: Increased delivery of taurine-conjugated bile acids to the distal bowel can lead to dysbiosis resulting in coli-
tis in mouse models of inflammatory bowel disease. A similar situation also could occur in cats with intestinal disease and
might therefore result in decreased whole-body taurine concentration.
Hypothesis/Objectives: To determine whether whole-blood taurine concentrations are decreased at the time of diagnosis
in cats with intestinal disease and to correlate concentrations with clinical and laboratory variables.
Animals: Twenty-one cats with chronic inflammatory enteropathy and 7 cats with intestinal neoplasia from the University
of Bristol.
Methods: Cats that had undergone a thorough investigation consisting of a CBC, serum biochemistry, serum cobalamin
and folate concentrations, transabdominal ultrasound examination and histopathology of intestinal biopsy specimens, as well
as additional testing if indicated, were included. Whole-blood from these cats collected at the time of histologic diagnosis and
stored in ethylenediaminetetraacetic acid was retrospectively analyzed for taurine with an automated high-performance liquid
chromatography amino acid analyzer.
Results: Although whole-blood taurine concentrations remained within the reference range, those cats with predominantly
large intestinal clinical signs had significantly lower concentrations than did cats with small intestinal and mixed bowel clini-
cal signs (P = 0.033) and this difference also was significant when assessed only in cats with chronic inflammatory enteropa-
thy (P = 0.019).
Conclusions and Clinical Importance: Additional studies are needed to determine whether large intestinal signs in cats with
chronic inflammatory enteropathy are caused by alterations in the microbiota arising as a consequence of increased delivery
of taurine-conjugated bile acids.
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Taurine is an essential amino acid in cats, becausethey lack the metabolic pathways to synthesize it
from the precursors methionine and cysteine.1 In addi-
tion, cats conjugate bile acids solely with taurine and
these conjugated bile acids are absorbed from the termi-
nal ileum.1 Therefore, clinically relevant ileal disease
may impair the absorption of taurine-conjugated bile
acids resulting in decreased whole-body taurine concen-
tration. A significantly higher number of taurine-conju-
gated bile acids has been reported in the feces of mice
with ileitis and colitis.2 Interestingly, a diet high in satu-
rated fat has been shown to increase the production
and delivery of taurine-derived sulfur to the large intes-
tine promoting an increase in bile-tolerant microbes
such as Bilophila wadsworthia, which promote a Th-1-
mediated immune response leading to development of
colitis in IL-10 knockout mice.3 Therefore, increased
delivery of taurine-derived sulfur to the distal bowel
might occur in cats resulting in large intestinal diarrhea
and a subsequent decrease in whole-body taurine con-
centration. Therefore, cats with intestinal disease may
have decreased whole-body taurine from 2 mechanisms:
as a result of decreased absorption of taurine-conju-
gated bile acids due to ileal disease and as a result of
increased production of taurine-conjugated bile acids
(e.g., due to increased cholecystokinin) which may lead
to increased delivery to the colon resulting in inflamma-
tion from alterations in the microbiota. These cats might
not be able to replenish their whole-body taurine concen-
trations especially in the presence of inappetence, anorex-
ia, vomiting, malabsorption, or a catabolic state. Taurine
deficiency can cause several metabolic abnormalities and
clinical signs, which may range from an inadequate
immune response to dilated cardiomyopathy.1
Determining whether cats with clinically relevant
intestinal disease have concurrent low whole-body tau-
rine concentration is important, given the potential role
of taurine in nearly every body system.1,4 Whole-blood
taurine is the most reliable measure of whole-body
status.1 Therefore, the aims of our study were to deter-
mine, firstly, whether whole-blood taurine concentration
at the time of diagnosis in cats with intestinal disease is
decreased and, secondly, to correlate taurine status with
chronicity of clinical signs; presence of inappetence,
weight loss, and diarrhea; localization of gastrointesti-
nal (GI) signs (small bowel, large bowel, or mixed
bowel); body condition score (BCS); serum cobalamin
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and folate concentrations; serum albumin concentra-
tion; histologic diagnosis; feline chronic enteropathy
activity index (FCEAI);5 and, diet history.
Materials and Methods
Retrospective Study Criteria for Case Selection
The histopathology archive at the University of Bristol was
searched for cats presented between January 2013 and December
2016 with a histologic diagnosis of chronic inflammatory enteropa-
thy or intestinal neoplasia. All medical records then were reviewed
by one of the authors (AK). Only cats with a histologic diagnosis
of chronic inflammatory enteropathy that had at least a 3-week
history of persistent or intermittent GI signs, and adequate and
appropriate investigations to exclude other causes of chronic GI
signs, and had been appropriately treated for GI parasites before
histologic diagnosis were included. Cats with chronic inflammatory
enteropathy that had not undergone a strict exclusion diet trial
before histologic diagnosis were included. The minimum diagnostic
evaluation performed on each cat included a CBC, serum bio-
chemistry, serum cobalamin and folate concentrations, transab-
dominal ultrasound examination, and collection of intestinal
biopsy specimens by endoscopy or exploratory laparotomy. Pan-
creatic testing (feline pancreatic lipase immunoreactivity and tryp-
sin-like immunoreactivity), serum thyroxine concentrations, basal
cortisol concentration, pre- and postprandial bile acid concentra-
tions, fecal parasitology using saturated zinc sulfate flotation, fecal
culture (for Salmonella, Campylobacter, and Clostridium difficile),
polymerase chain reaction for Tritrichomonas foetus, and feline
leukemia and feline immunodeficiency virus testing also were per-
formed in some cats, as indicated by the history, physical examina-
tion and ultrasound examination findings.
Data Collection
Medical records were reviewed for each cat and the signalment;
clinical history including duration, presence of inappetence,
lethargy, weight loss, vomiting, and large or small intestinal diar-
rhea; complete diet history; BCS; and results of diagnostic tests
including laboratory, transabdominal ultrasound examination find-
ings, endoscopic findings, and histopathology report were col-
lected. The FCEAI was calculated for cats with chronic
inflammatory enteropathy.5
Clinical signs were localized to the small bowel if weight loss,
borborygmi, vomiting, large volume diarrhea, normal frequency of
defecation, melena, and lack of urgency were identified. Large
bowel was defined as diarrhea that was smaller in volume and
characterized by increased frequency of defecation, mucus or fresh
blood, straining, and increased urgency.
To determine whether the diet each cat was consuming com-
plied with the recommendations of the World Small Animal
Veterinary Association (WSAVA) Global Nutrition Committee,
each manufacturer was contacted and asked to reply to the 8 ques-
tions outlined in section A of the web link.a Diets were considered
to meet the recommendations outlined by the WSAVA Global
Nutrition Committee if the manufacturer could satisfactorily
address all of the questions.
Whole-Blood Taurine Analysis
For each cat, whole-blood stored in ethylenediaminetetraacetic
acid (EDTA) at 20°C from the time of histologic diagnosis was
retrieved from the DNA archive at the University of Bristol and
sent to the Amino Acid Laboratory at the University of Califor-
nia, Davis, for taurine analysis. Whole-blood taurine
concentrations were analyzed with an automated high-performance
liquid chromatography amino acid analyzer,b by a method
described elsewhere.6
Although studies in humans have confirmed the stability of tau-
rine when frozen for at least 14 months,7 whole-blood from 4
blood donor cats that was stored in EDTA at 20°C for 2 years
also was retrieved from the DNA archive at the University of Bris-
tol and sent to the Amino Acid Laboratory at the University of
California, Davis, for taurine analysis to ensure that prolonged
freezing did not falsely decrease concentrations below the reference
range.
Ethical Considerations
Stored residual blood was used in this study and the University
of Bristol granted ethical approval for the study (VIN/14/017).
Data Analysis and Statistics
Analyses were performed by a computer software package.c A
Mann-Whitney U-test was used to assess for significant differences
in whole-blood taurine concentration in cats with chronic inflam-
matory enteropathy versus those with intestinal neoplasia, cats
with inappetence versus normal appetite, cats with weight stability
versus those with weight loss, cats with diarrhea versus those with
normal feces, cats with predominantly large intestinal clinical signs
versus cats with predominantly small intestinal clinical signs, cats
with clinical signs for >12 months versus those with signs for
≤12 months, cats with normocobalaminemia versus those with
hypocobalaminemia, cats with increased serum folate concentra-
tions versus those with normal serum folate concentrations, cats
with hypocobalaminemia and concurrent increased serum folate
concentrations versus those without these biochemical findings,
and cats consuming diets that met the recommendations outlined
by the WSAVA Global Nutrition Committee versus diets that did
not meet these recommendations.
A Spearman’s rank correlation coefficient was used to assess
whether there were significant correlations between whole-blood
taurine and serum cobalamin, folate, or albumin concentrations,
duration of clinical signs, FCEAI, BCS, and age at diagnosis.
Results are reported as median and range. Significance was defined
as P < 0.05.
Results
Cats
Twenty-eight cats were included in the study: 1 intact
male, 15 neutered male, 1 intact female, and 11 neu-
tered female. The age of the cats ranged from 6 months
to 13 years, with a median age of 6 years. Fourteen cats
were Domestic Shorthair, 3 Maine Coon, 2 Siamese, 2
Birman, 2 Domestic Longhair, and 1 each of the fol-
lowing breeds: Bengal, Bengal cross, Tonkinese, British
Blue, and British Shorthair. Body condition score ran-
ged from 1/9 to 6/9, with a median of 4/9.
All 4 blood donor cats were neutered males, domestic
shorthaired, and 10 months of age.
History
Nine cats had GI signs for >12 months, whereas 19
cats had signs for ≤12 months. Duration of signs for all
cats ranged between 3 weeks and 84 months (median,
8.5 months). Eighteen cats had weight loss and 10 cats
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had stable body weight before diagnosis. Twelve cats
were inappetent and 16 cats had normal appetite at the
time of diagnosis. Sixteen cats had diarrhea and 12 cats
had no history of diarrhea. The pattern of diarrhea was
exclusively small intestinal (n = 3), predominantly small
intestinal (n = 4), exclusively large intestinal (n = 4),
predominantly large intestinal (n = 1), or mixed bowel
(n = 4). Twenty-one cats were eating a diet that met the
recommendations outlined by the WSAVA Global
Nutrition Committee at the time of diagnosis, whereas
7 cats were not. The reason the diets these 7 cats were
eating did not meet the recommendations outlined by
the WSAVA Global Nutrition Committee was because
the manufacturers of these diets did not employ full-
time qualified nutritionists and could not provide a
complete nutrient analysis for the cat foods in question.
Twenty-three cats were receiving no treatment for their
intestinal disease at the time of retrospective whole-
blood taurine analysis. Of the 5 cats receiving
treatment, 1 was treated with metronidazole, 1 with
metronidazole and omeprazole, 1 with amoxicillin-cla-
vulanate, 1 with famotidine, and 1 with ondansetron,
ranitidine, and maropitant.
Histologic Diagnosis
Seven of the 28 cats were diagnosed with intestinal
neoplasia: small cell intestinal lymphoma (n = 5), large
cell intestinal lymphoma (n = 1), and adenocarcinoma
of the proximal ileum (n = 1). All biopsy specimens
were collected by endoscopy, except for the cat with an
adenocarcinoma, in which diagnosis was made by
exploratory laparotomy. Twenty-one cats were diag-
nosed with chronic inflammatory enteropathy. Six had
diffuse mixed bowel inflammation, with 1 each of the
following: lymphoplasmacytic enteritis and colitis;
mixed cell enteritis and colitis; eosinophilic enteritis and
colitis; eosinophilic and neutrophilic enteritis and colitis;
lymphoplasmacytic, neutrophilic, and eosinophilic
enteritis; and colitis, lymphoplasmacytic enteritis, and
mixed cell colitis. Twelve of the 21 cats were diagnosed
with small intestinal inflammation alone: mixed cell
enteritis (n = 4), lymphoplasmacytic enteritis (n = 2),
eosinophilic enteritis (n = 2), and 1 each of the follow-
ing: lymphocytic enteritis, lymphoplasmacytic and eosi-
nophilic enteritis, lymphoplasmacytic and neutrophilic
enteritis, and eosinophilic and neutrophilic enteritis.
Large intestinal inflammation alone was diagnosed in 3
of the 21 cats: 1 each of lymphoplasmacytic colitis,
mixed cell colitis, and lymphoplasmacytic and neu-
trophilic colitis. For the cats diagnosed with chronic
inflammatory enteropathy, biopsy specimens were col-
lected by endoscopy in 18 cats and by exploratory
laparotomy in 3. For these cats, the FCEAI ranged
from 4 to 8, with a median of 5.
Serum Cobalamin, Folate, and Albumin
Concentrations
Twenty-one cats were normocobalaminemic (median,
635 ng/L; range, 259 to >1,000 ng/L; reference range,
220–500 ng/L), but 3 of the cats had received
cyanocobalamin supplementation SC before analysis,
and 7 cats were hypocobalaminemic (median, 111 ng/L;
range, <111–207 ng/L) at the time of diagnosis. Four-
teen cats had serum folate concentrations within the
reference range (median, 29.4 nmol/L; range, 21.1–
36.5 nmol/L; reference range 19–37 nmol/L) and 14 cats
had concentrations above the reference range (median,
46.1; range, 38.1–54.4 nmol/L). Of the 14 cats with
serum folate concentrations above the reference range,
4 had concurrent hypocobalaminemia, suggestive of
possible dysbiosis. Twenty-four cats were normoalbu-
minemic (median, 2.85 g/dL; range, 2.42–3.24 g/dL; ref-
erence range, 2.4–3.5 g/dL) and 4 cats were
hypoalbuminemic (median, 2.34 g/dL; range, 2.20–
2.37 g/dL) at the time of diagnosis.
Whole-Blood Taurine Concentration
Twenty-seven of the 28 cats had whole-blood taurine
concentrations higher than the lower end of the
reported reference range of 275–701 nmol/mL.8 The
only cat that had whole-blood taurine concentration
below the reported reference range, at 267 nmol/mL,
had a proximal ileal adenocarcinoma. Additional areas
of intestine were not biopsied in this cat, but histologic
examination of an intestinal segment proximal to the
ileal mass showed clear margins with no evidence of
neoplasia, but multifocal fibrosis and a focal marked
increase in eosinophils within the lamina propria were
observed. This cat had a 3-month history of intermit-
tent vomiting and weight loss with good appetite and
the cat was eating a diet that met the recommendations
outlined by the WSAVA Global Nutrition Committee.
The cat was reported to have normal feces and a BCS
of 6/9. The cat had normal serum cobalamin, folate,
and albumin concentrations without supplementation at
the time of diagnosis (620 ng/L, 33.8 nmol/L, and
2.85 g/dL, respectively). All 4 blood donor cats had
whole-blood taurine concentrations within the reference
range (median, 407 nmol/mL; range, 328–490 nmol/
mL).
Differences in Whole-Blood Taurine Concentration for
Various Variables
There were no significant differences (P > 0.3)
between whole-blood taurine concentrations (n, median
[nmol/mL], range [nmol/mL]) in cats with chronic
inflammatory enteropathy (n = 21, 398, 297–731) versus
intestinal neoplasia (n = 7, 537, 267–920); with inappe-
tence (n = 12, 429, 297–614) versus normal appetite
(n = 16, 427, 267–920); with stable body weight (n = 10,
421, 297–731) versus weight loss (n = 18, 427, 267–920);
with diarrhea (n = 16, 391, 297–920) versus normal
feces (n = 12, 446, 267–638); with clinical signs for
>12 months (n = 9, 398, 336–614) versus those with
signs for ≤12 months (n = 19, 444, 267–920); cats with
normocobalaminemia (n = 21, 447, 267–920) versus
hypocobalaminemia (n = 7, 384, 340–550); cats with
normal serum folate concentration (n = 14, 428, 267–920)
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versus increased serum folate concentration (n = 14,
421, 340–614); cats with hypocobalaminemia and con-
current increased serum folate concentration (n = 4,
446, 340–550) versus those without these findings
(n = 24, 427, 267–920); and cats consuming a diet that
met the recommendations outlined by the WSAVA Glo-
bal Nutrition Committee (n = 21, 444, 267–920) versus
those that did not meet the guidelines (n = 7 cats, 380,
336–638).
All cats with predominantly or exclusively large
intestinal clinical signs (n = 5, 355, 348–384) had a sig-
nificantly lower whole-blood taurine concentration
(P = 0.033) than cats with small intestinal and mixed
bowel clinical signs (n = 23, 459, 267–920; Fig 1). Sta-
tistical significance (P = 0.019) also was found when
only cats with a diagnosis of chronic inflammatory
enteropathy were evaluated, comparing those with large
intestinal clinical signs (n = 5, 355, 348–384) versus
those with small intestinal and mixed bowel clinical
signs (n = 16, 452, 297–731). Four of the 5 cats with
large intestinal signs had histologic evidence of colitis,
the remaining 1 cat had biopsy samples collected by
exploratory laparotomy, and therefore, biopsy of the
colon was not performed to document the presence of
inflammation.
Correlation Between Whole-Blood Taurine
Concentration and Various Variables
No significant correlations (P > 0.5) were found
between whole-blood taurine and serum cobalamin,
serum folate, or serum albumin concentrations; dura-
tion of clinical signs; FCEAI; BCS; and age at
diagnosis.
Discussion
In our study, whole-blood taurine concentrations
were measured at the time of diagnosis in 28 cats with
intestinal disease. Taurine is an essential nutrient in
cats, because they lack the metabolic pathways to syn-
thesize sufficient amounts from the amino acid precur-
sors methionine and cysteine to meet obligatory losses.1
Clinically relevant ileal disease might impair the absorp-
tion and recycling of taurine-conjugated bile acids. In
addition, increased production of taurine-conjugated
bile acids from increased cholecystokinin release9 might
result in increased delivery to the colon resulting in
inflammation, either from direct irritation of the muco-
sal lining or as a result of alterations in the microbiota.
Therefore, cats with intestinal disease might be at risk
for developing decreased whole-body taurine concentra-
tions, especially if they are not able to replenish their
stores by increased PO intake of a complete and bal-
anced diet.
Taurine plays a crucial role in the immune
system,10,11 and therefore, a deficiency might impair the
ability of the GI tract to recognize and mount an
appropriate immune response. This effect may be partic-
ularly concerning in cats with chronic inflammatory
enteropathy in which it is suspected that an aberrant
immune system might already play a role in the patho-
genesis of the disease. Therefore, documenting whether
cats with intestinal disease have taurine deficiency is
warranted because a deficiency might further affect the
pathogenesis and treatment of the disease. To our
knowledge, our study is the first to document whole-
blood taurine concentrations at the time of diagnosis in
cats with intestinal disease.
We found that at the time of diagnosis, all but 1 cat
with intestinal disease had whole-blood taurine concen-
trations within the reported reference range. Therefore,
whole-blood taurine was not substantially depleted in
this population of cats with intestinal disease. Although
1 cat had whole-blood taurine concentration below the
reference range, it was still >200 nmol/mL, and there-
fore, clinical signs of deficiency would not be expected.1
This cat had a 3-month history of intermittent vomiting
and weight loss, but a normal appetite and was con-
suming a diet that met the recommendations outlined
by the WSAVA Global Nutrition Committee. In addi-
tion, this cat had normal fecal quality, BCS of 6/9, and
had serum cobalamin, folate, and albumin concentra-
tions within reference ranges. Although the pathomech-
anism of decreased whole-blood taurine concentration
was unknown for this cat, it was unlikely to have been
caused by the type of diet nor decreased absorption and
recycling as a consequence of ileal disease because the
serum cobalamin concentration was within the reference
range. However, although sections proximal to the mass
documented fibrosis and eosinophilic infiltration, addi-
tional biopsy specimens were not taken from the
Fig 1. Box and whisker plot of whole-blood taurine concentra-
tion at the time of diagnosis in cats with exclusively or predomi-
nantly large intestinal clinical signs and cats with small intestinal
and mixed clinical signs. Box and whisker plot of whole-blood tau-
rine concentration at the time of diagnosis in cats with intestinal
disease. Large intestinal signs—5 cats, minimum—348 nmol/mL,
maximum—384 nmol/mL, median—355 nmol/mL, range—
36 nmol/mL, interquartile range—22 nmol/mL. Small intestinal
and mixed bowel signs—23 cats (19 small intestinal and 4 mixed
bowel), minimum—267 nmol/mL, maximum—920 nmol/mL, med-
ian—459 nmol/mL, range—653 nmol/mL, interquartile range—
170 nmol/mL.
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intestinal tract to determine the extent of any concur-
rent disease. Although the 3-month history of weight
loss and intermittent vomiting might have contributed
to the decreased whole-blood taurine concentration in
this cat, it is likely that a second factor also was pre-
sent. Bacterial overgrowth or dysbiosis in the ileum
associated with changes in the local environment from
the adenocarcinoma or concurrent disease might have
resulted in increased cleavage of taurine-conjugated bile
acids with subsequent oxidation of taurine by microbes.
This would have prevented reutilization12–14 and there-
fore could also account for the decreased taurine in this
cat. However, in our study, cats with suspected dysbio-
sis based on low serum cobalamin and increased serum
folate concentrations did not have significantly
decreased whole-blood taurine concentrations. This
finding may have been a result of decreased power of
the study based on the small number of cats with these
biochemical findings. In addition, the relative insensitiv-
ity of low serum cobalamin and increased serum folate
concentrations at determining the presence of dysbiosis
also may have resulted in nonsignificance. Therefore,
future studies should focus on analysis of the fecal
microbiota to definitively determine whether the pres-
ence of dysbiosis alters the metabolomics in such cats.
Interestingly, our study documented that cats with
exclusively or predominantly large intestinal signs had
significantly lower whole-blood taurine concentrations
than did cats with small intestinal or mixed bowel signs,
and this finding also was statistically significant when
only cats with chronic inflammatory enteropathy were
analyzed. However, this finding was based on a small
number of cats in the large intestinal group, and whole-
blood taurine concentration still overlapped between
the 2 groups (Fig 1). Therefore, a larger number of cats
would be needed to corroborate the preliminary find-
ings of our study. A sample size calculation based on
the results of our study indicated that 23 cats with large
intestinal signs and 23 cats with small intestinal signs
would be needed to detect a statistically significant dif-
ference after adjusting for multiple comparisons.
Because of the pilot design of our study and suspected
decreased power from the limited number of cases in
the large intestinal group, the results were not corrected
for multiple comparisons because of concern for type II
error. Therefore, the results from our study justify com-
pletion of a larger study to corroborate these findings
and warrant the performance of metabolomic studies in
cats with intestinal disease.
When comparing the effects of disease location on
whole-blood taurine concentration, clinical signs rather
than histologic findings were used because not all cats
had colonic biopsies performed. In addition, some cats
were diagnosed with colitis based on histopathology,
but either did not have consistent large intestinal signs
or such signs represented a less relevant component of
their clinical presentation.
One study documented that a diet high in saturated
fat increases the production and delivery of taurine-
derived sulfur to the distal bowel, promoting an
increase in bile-tolerant microbes (eg B. wadsworthia)
that promote a Th-1-mediated immune response leading
to development of colitis in IL-10 knockout mice.3 Sim-
ilarly, increased delivery of taurine-derived sulfur to the
distal bowel might occur in cats and result in large
intestinal diarrhea as a result of an alteration in the
microbiota, with a subsequent decrease in whole-blood
taurine concentration compared to cats with small
intestinal or mixed bowel clinical signs. However, addi-
tional studies documenting a significant difference in
fecal taurine concentration in cats with large and small
intestinal disease would be needed to confirm this possi-
bility. A distinct fecal bile acid profile has been
observed with significantly higher concentrations of tau-
rine-conjugated bile acids in IL-10 knockout mice with
ileitis and colitis.2 Similarly, feces from humans with
inflammatory bowel disease contained more bile acids
and taurine, and this metabolite pattern was highly cor-
related with a characteristic shift in the microbiota.15
One study documented that the increased conjugated
and sulfated bile acids in the feces of humans with
Crohn’s disease was attributed to the decreased capacity
of the microbiome in these patients to deconjugate and
desulfate bile acids, resulting in decreased production in
the colon of secondary bile acids, which are normally
anti-inflammatory.16 Therefore, the increase in fecal tau-
rine seen in human and animal models of inflammatory
bowel disease likely results from a perturbation in
microbiota, and consequently, bile acids may form the
link between the dysbiosis and inflammation seen in
these diseases. Similarly, taurine-conjugated bile acids
might cause or exacerbate large intestinal inflammation
in cats by altering the microbiota. However, additional
studies (especially fecal metabolomics) as well as analy-
sis of the microbiota are needed to determine whether
cats with large intestinal disease have increased fecal
taurine and whether the microbiota in these cats differs
from those in cats that do not have increased fecal tau-
rine. If taurine-conjugated bile acids play a role in large
intestinal inflammation in cats, then additional studies
may focus on the role of dietary fat in minimizing the
production and secretion of these bile acids, because
increased cholecystokinin, which may be stimulated by
dietary fat, increases bile secretion in cats resulting in
more luminal taurocholic acid.9 Although, 1 study
reported no effect of different amounts of dietary fat on
fecal consistency in cats with diarrhea, this study did
not specifically document the effect of different amounts
of fat in those cats with predominantly or exclusively
large intestinal disease.17 In addition, certain fibers and
peptides are able to bind to taurine-conjugated bile
acids, resulting in excess loss of taurine in the feces.18,19
These fibers and indigestible protein also may support
the microbiota, which can cleave these bile acids result-
ing in increased loss of free taurine.1 In cats, indi-
gestible peptides also can increase cholecystokinin
production,9 which increases luminal taurocholic acid.
Therefore, if further investigation confirms the role of
taurine in intestinal disease in cats, additional studies to
assess the impact of certain fibers and peptides on lumi-
nal taurine in cats with intestinal disease may be
needed.
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Surprisingly, we did not identify any significant differ-
ences in whole-blood taurine concentrations between
cats with normal appetite versus those with inappetence,
between those with stable body weight versus those with
weight loss, or between cats consuming a diet that met
the recommendations outlined by the WSAVA Global
Nutrition Committee versus those consuming diets that
did not meet the recommendations. Also, no correlation
was found between whole-blood taurine concentrations
and duration of clinical signs, and none was found with
serum cobalamin, folate, or serum albumin concentra-
tions. These findings might be because taurine depletion
must occur over months to years, depending on the
extent of the deficiency,1 and therefore, correlating con-
centrations to specific clinical signs or laboratory find-
ings might be difficult over a shorter time frame.
Although the median duration of clinical signs for cats
in our study was 8.5 months, this time frame might not
have been long enough to cause significant changes or
correlations. In addition, individual need for taurine
depends on diet composition, especially the type, quan-
tity, and digestibility of protein and fiber.1 Unfortu-
nately, because of the retrospective nature of our study,
it was not possible to obtain detailed information about
the diets, apart from the name and type of food being
fed at the time of diagnosis when the cats were pre-
sented to the University of Bristol. However, for the
majority of the cats, previous diets from at least the last
few years were available from the referring veterinari-
ans’ records. However, given that the time span for
inclusion into the study covered 4 years, it was not pos-
sible to accurately correlate the different macronutrient
profiles with whole-blood taurine concentration.
Given studies on the effect of dietary fat on tauro-
cholic acid production in mice and cats,3,9 correlating
this effect to whole-blood taurine concentrations might
have been informative. Another limitation of our study
involved its retrospective design, which could have made
the interpretation of the clinical history and assignment
of the FCEAI scores inconsistent because of the involve-
ment of several clinicians in the cases and the fact that 2
of the variables used for assessment of the activity index
(lethargy and appetite) involved a subjective scale.5 In
addition, although all cats with chronic inflammatory
enteropathy were normobilirubinemic, did not have evi-
dence of hepatic damage on serum biochemistry results,
and had normal liver and biliary tree on abdominal
imaging, pre- and postprandial bile acid concentrations
to eliminate hepatic dysfunction definitively were not
measured for all cats. Therefore, the presence of possible
concurrent hepatic dysfunction, although considered
unlikely, could not be definitively eliminated in all cats.
Therefore, a prospective study to evaluate whole-blood
taurine concentrations in cats with intestinal disease
would allow for consistent assessment of the clinical his-
tory in all cases as well as collection of a detailed diet
history for macronutrient profiling as well as pre- and
postprandial bile acid concentrations to definitively elim-
inate hepatic dysfunction.
Five cats in our study were receiving medications at
the time of retrospective taurine analysis. Three of
these cats were receiving either metronidazole or
amoxicillin-clavulanate. Metronidazole use alone has
less effect than do antibiotic combinations on bile acid
profiles in mice,20 and amoxicillin was shown not to
affect fecal and plasma bile acid concentrations in
humans.21 However, additional studies are needed to
determine whether these antibiotics have the same lim-
ited effect on blood bile acid profiles in cats with
intestinal disease. Three of the cats in our study
also were receiving antacid treatment (omeprazole,
famotidine, and ranitidine) and 2 of the 5 cats were
receiving antiemetic medications (ondansetron and
maropitant). Famotidine was shown not to affect
serum bile acid concentrations in healthy humans.22
Although 1 study in humans showed that omeprazole
significantly lowered the concentration of taurine-con-
jugated bile acids as a result of bacterial overgrowth,23
only 1 cat in our study was receiving this medication.
The results of our study still were significant when this
1 cat was removed from statistical analysis, with cats
that had predominantly large intestinal clinical signs
having significantly lower whole-blood taurine concen-
trations than cats with small intestinal and mixed
bowel clinical signs (P = 0.040), and this finding also
was significant when assessed only in cats with chronic
inflammatory enteropathy (P = 0.025). However, future
studies should consider the medications that the cats
are receiving at the time of taurine analysis to elimi-
nate any confounding effects from the use of these
medications.
In conclusion, we documented whole-blood taurine
concentrations at the time of diagnosis in cats with
intestinal disease. Although our study indicated that
cats with predominantly or exclusively large intestinal
signs had significantly lower whole-blood taurine con-
centrations compared to cats with small intestinal or
mixed bowel signs, the concentrations remained within
the reference range. Thus, additional studies, particu-
larly those assessing fecal taurine concentration and
analysis of the microbiota, are needed in cats with large
intestinal and small intestinal disease to determine the
role of bile acids and taurine in the pathogenesis of
chronic inflammatory enteropathy.
Footnotes
a World Small Animal Veterinary Association (WSAVA) Global
Nutrition Committee Guidelines: http://www.wsava.org/sites/defa
ult/files/Recommendations%20on%20Selecting%20Pet%20Food
s.pdf.
b Biochrom 30, Biochrom Ltd, Holliston, MA
c IBM SPSS Statistics version 23, Armonk, NY, USA
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